TABLE 6.
International comparison of affordability of standard treatments.
| Country | Survey year | WB country income group | WHO region | Atenolol 50 mg tab | Amlodipine 5 mg tab | Captopril 25 mg cap/tab | Simvastatin 20 mg | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OB | LPG | OB | LPG | OB | LPG | OB | LPG | ||||
| Pakistan | 2019 | LMI | EMR | 5.4 | 1.8 | 14.2 | 2.2 | 5.1 | 4.1 | 9.8 | 1.7 |
| Sudan | 2013 | LMI | EMR | 5.2 | 0.5 | NA | 0.8 | NA | 3.2 | NA | 2 |
| Lebanon | 2013 | UMI | EMR | 0.7 | 0.2 | 1 | 0.7 | 1.3 | 0.7 | 1.8 | 0.3 |
| Egypt | 2013 | LMI | EMR | 0.4 | 0.1 | 1.7 | 0.6 | 0.8 | 0.5 | 4.3 | 2.1 |
| India | 2011 | LMI | SEAR | 0.4 | 0.4 | 1 | 0.3 | NA | 1.1 | 2.2 | 0.6 |
| Afghanistan | 2011 | LI | EMR | NA | 0.2 | NA | NA | NA | 0.4 | NA | 1.1 |
| China | 2014 | UMI | WPR | NA | NA | 3.7 | 0.8 | NA | NA | 2.6 | 1.3 |
WB, World Bank; LMI, Lower Middle Income; UMI, Upper Middle Income; LI, Low Income; EMR, Eastern Mediterranean Region; SEAR, South East Asia Region; WPR, Western Pacific Region.